Skip To Main Content
Preston-Hurlburt P on Muck Rack

Preston-Hurlburt P

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Preston-Hurlburt

Contact Preston-Hurlburt, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Latent EBV impairs immune cell signaling and enhances the efficacy of anti-CD3 mAb in Type 1 Diabetes

|
By Sumida TS, Long Sa, Delgado AL, Preston-Hurlburt P
| nlm.nih.gov
This is a preprint. It has not yet been peer reviewed by a journal. The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed. Display options Abstract Teplizumab has been approved for the delay of the onset of type 1 diabetes and may modulate new onset disease.
Open in Who Shared Issue with article?
See all 1 articles